Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
FDA · 23 medicines
SFDA · 16 medicines · Historical list
AEMPS · 8 medicines
CBG-MEB · 6 medicines
HSA · 6 medicines
AIFA · 4 medicines
PHARMAC · 3 medicines
ALIMS · 2 medicines
TFDA · 2 medicines · Historical list
HALMED · 1 medicine
MS · 1 medicine · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
155 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Tretinoin | United States | 10MG | capsule | Marketed | Barr Labs INC |
| Tretinoin | United States | 0.025%, 0.0375%, 0.05% … | cream | Marketed | Encube |
| Tretinoin | United States | 0.01%, 0.025%, 0.04% … | gel | Marketed | Rising |
| Tretinoin | United States | 0.05% | solution | Not marketed | Teva Pharms |
| tretinoína | Brazil | Authorised | Ems S/A | ||
| Tretinoin Microsphere | United States | 0.06%, 0.08% | gel | Marketed | Encube |
| Tretinoina Same | Italy | Crema | Authorised | Savoma Medicinali S.P.A. | |
| Jamp Tretinoin | Canada | 10 MG | Capsule | Marketed | Jamp Pharma Corporation |
| Clindamycin Phosphate and TretinoinCombination | United States | 1.2%; 0.025% | gel | Marketed | Actavis Mid Atlantic |
| Retin-A | United States | 0.025%, 0.05%, 0.1% | cream | Marketed | Valeant Pharms North |
| Retin-A | United States | 0.01%, 0.025% | gel | Marketed | Valeant Intl |
| Retin-A Micro | United States | 0.04%, 0.1% | gel | Marketed | Bausch |
| Retin-A-Micro | United States | 0.06%, 0.08% | gel | Marketed | Bausch |
| Altreno | United States | 0.05% | lotion | Marketed | Dow Pharm |
| Atralin | United States | 0.05% | gel | Marketed | Dow Pharm |
| Retin-A | United States | 0.05% | solution | Not marketed | Valeant Intl |
| Retin-A | United States | 0.05% | swab | Not marketed | Valeant Intl |
| Hidroquinona+ Tretinoina + Fluocinolona AcetonidaCombination | Brazil | Authorised | Ems S/A | ||
| Avita | United States | 0.025% | cream | Marketed | Mylan Pharms INC |
| Renova | United States | 0.02%, 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | cream | Marketed | Valeant Pharms North |
| Vesanoid | United States | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | capsule | Not marketed | Cheplapharm |
| Avita | United States | 0.025% | gel | Not marketed | Rising |
| Retin-A | Canada | 0.05 % / W/W | Cream | Marketed | Bausch Health, Canada INC. |
| Retin-A | Canada | 0.025 % / W/W | Gel | Marketed | Bausch Health, Canada INC. |
| Tretinon Cream 0.05% W/W | Singapore | 0.05 % w/w | cream | Authorised | Yung Shin Pharmaceutical (Singapore) Pte LTD |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
